最新的帖子

三月 12, 2021

Is home-based administration possible? Exploring the intravenous to subcutaneous transition in cancer treatments.

Imagine self-administered cancer treatments in the comfort of a patient&rsquo;s home. How close are we to making this a reality? During this unprecedented time, immuno-compromised patients can benefit from receiving a self-administered, home-based treatment option. One major factor into making home-based cancer treatment a reality is a focus on shifting the route of administration from intravenous to subcutaneous delivery. Due to an emphasis on patient involvement in shared decision making for health care policy and medical approaches, understanding the intravenous to subcutaneous transition in medical injections has garnered increased importance. If therapeutic efficacy is not compromised, the less invasive nature and convenience of subcutaneous injections is often the preferred route of administration.<sup>1-2,4-6</sup>

Aaron Chapman, PhD

Program Manager, Commercial Technology Development

以前的博客

二月 04, 2021

West Recognizes World Cancer Day 2021

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Patient with nurse getting treatment

九月 16, 2020

Why a Diagnosis of Leukemia Means a Possibly Complicated Journey Ahead

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

SmartDose Platform

六月 27, 2019

Industry Trends in Biologic Formulations

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

CPhI China Tradeshow

六月 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

SmartDose In-Use

五月 07, 2019

The Impact Poor Formulations Have on Drug Development Programs

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Load more